Up Next
Back to Show
Aging Matters
How Gene Therapy Could Change Vision Loss
At 88, Anette McRay faced fading vision from age-related macular degeneration and endured constant eye injections to slow her vision loss. But after she joined an experimental gene therapy trial at Vanderbilt Eye Institute, her sight, as well as her independence, is being preserved, offering hope for millions facing the same devastating disease.
Support Provided By
26:46
Veterans may struggle with shifts in roles, responsibilities, & relationships as they age.
26:46
More than 76,000 grandparents in Tennessee are responsible for their grandchildren.
2:30
Finding purpose in retirement can be critical to our overall well-being.
26:46
Nontraditional workers navigate life without the security of health & financial benefits.
26:46
Women Unseen covers issues of older women, e.g. outliving partners and aging into poverty.
26:46
Internet crime is at an all-time high. Arming yourself with knowledge is the best defense.